Erastin is a ferroptosis inducer. Erastin exhibits the mechanism of ferroptosis induction related to ROS and iron-dependent signaling. Erastin inhibits voltage-dependent anion channels (VDAC2/VDAC3) and accelerates oxidation, leading to the accumulation of endogenous reactive oxygen species. Erastin also disrupts mitochondrial permeability transition pore (mPTP) with anti-tumor activity
Statement: 
->>Products covered by valid patents are not offered or supplied for commercial use. 
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1). 
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.


 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				        